BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 6152481)

  • 21. Disorders of movement: a mercifully short primer.
    Weinmann RL
    Dis Nerv Syst; 1975 Feb; 36(2):84-6. PubMed ID: 163723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
    Yamamura S; Ohoyama K; Nagase H; Okada M
    Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
    Bernheimer H; Birkmayer W; Hornykiewicz O; Jellinger K; Seitelberger F
    J Neurol Sci; 1973 Dec; 20(4):415-55. PubMed ID: 4272516
    [No Abstract]   [Full Text] [Related]  

  • 24. The basal ganglia in Parkinson's disease: current concepts and unexplained observations.
    Obeso JA; Marin C; Rodriguez-Oroz C; Blesa J; Benitez-Temiño B; Mena-Segovia J; Rodríguez M; Olanow CW
    Ann Neurol; 2008 Dec; 64 Suppl 2():S30-46. PubMed ID: 19127584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions.
    Scheel-Krüger J
    Adv Neurol; 1984; 40():85-90. PubMed ID: 6141713
    [No Abstract]   [Full Text] [Related]  

  • 26. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
    Belluscio MA; Riquelme LA; Murer MG
    Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surgical treatment of Parkinson's disease].
    Maciaczyk J; Swietaszczyk C; Kasprzak HA
    Przegl Lek; 2004; 61(12):1383-8. PubMed ID: 15850334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of excitotoxins in heredito-degenerative neurologic diseases.
    Young AB
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():175-89. PubMed ID: 8093331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Abnormal neurotransmission in neurological diseases (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1979; 24(2):150-9. PubMed ID: 35816
    [No Abstract]   [Full Text] [Related]  

  • 30. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
    Perry TL; Hansen S; Kloster M
    N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
    [No Abstract]   [Full Text] [Related]  

  • 31. The metabolism of brain dopamine in human parkinsonism.
    Hornykiewicz O
    Riv Patol Nerv Ment; 1970 Oct; 91(5):281-6. PubMed ID: 5525774
    [No Abstract]   [Full Text] [Related]  

  • 32. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD; Halliday GM
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
    Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
    Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The striopallidal system: Its implication in motor disorders.
    Poirier LJ; Parent A; Roberge AG
    Pathobiol Annu; 1975; 5():339-67. PubMed ID: 812038
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuropeptides in neurological disease.
    Beal MF; Martin JB
    Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 39. Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia.
    Marino MJ; Awad H; Poisik O; Wittmann M; Conn PJ
    Amino Acids; 2002; 23(1-3):185-91. PubMed ID: 12373536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemistry of dementia: establishing the links.
    Whitehouse PJ; Gambetti P; Harik SI; Kalaria RN; Perry G; Younkin SI; Tabaton M; Unnerstall JR
    Prog Clin Biol Res; 1989; 317():131-42. PubMed ID: 2574868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.